Baseline mood-state measures as predictors of antidepressant response to scopolamine

Psychiatry Research

Volumn 196, Issue 1, 2012, Pages 62-67

  Furey, Maura L ^a   Nugent, Allison C ^a   Speer, Andrew M ^a   Luckenbaugh, David A ^a   Hoffman, Elana M ^a   Frankel, Erica ^a   Drevets, Wayne C ^b,c   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^c Oklahoma University College of Medicine   (United States)

Author keywords

Bipolar disorder; Major depressive disorder; Mood disorders; Response prediction; Scopolamine

Indexed keywords

PLACEBO; SCOPOLAMINE;

ANTIDEPRESSANT ACTIVITY; ARTICLE; BIPOLAR DEPRESSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL IRRITATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DISCRIMINANT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SCOPOLAMINE HYDROBROMIDE; SELF REPORT;

EID: 84860602634     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.01.003     Document Type: Article

References (34)

1. Bradley B.P., Mogg K., Millar N. Implicit memory bias in clinical and non-clinical depression. Behaviour Research and Therapy 1996, 34:865-879.
2. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. American Journal of Psychiatry 2004, 161:598-607.
3. Costanza M.C., Afifi A.A. Comparison of stopping rules in forward stepwise discriminant analysis. Journal of the American Statistical Association 1979, 74:777-785.
4. Diagnostic and Statistical Manual of Mental Disorders IV, 2000. American Psychiatric Association, Washington, DC.
5. Drevets W.C., Furey M.L. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biological Psychiatry 2009, 67:432-438.
6. Elliott R., Rubinsztein J.S., Sahakian B.J., Dolan R.J. Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study. Neuroreport 2000, 11:1739-1744.
7. Fava M., Uebelacker L.A., Alpert J.E., Nierenberg A.A., Pava J.A., Rosenbaum J.F. Major depressive subtypes and treatment response. Biological Psychiatry 1997, 42:568-576.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P, 11/2002 Revision) 2002, New York State Psychiatric Institute, New York.
9. Furey M.L., Drevets W.C. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Archives of General Psychiatry 2006, 63:1121-1129.
10. Furey M.L., Khanna A., Hoffman E.M., Drevets W.C. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology 2010, 35:2479-2488.
11. Garriock H.A., Hamilton S.P. Genetic studies of drug response and side effects in the STAR*D study, part 1. The Journal of Clinical Psychiatry 2009, 70:1186-1187.
12. Hamilton M. The assessment of anxiety states by rating. The British Journal of Medical Psychology 1959, 32:50-55.
13. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., Goodwin G.M., Cowen P.J. Effect of acute antidepressant administration on negative affective bias in depressed patients. American Journal of Psychiatry 2009, 166:1178-1184.
14. Insel T.R., Wang P.S. The STAR*D trial: revealing the need for better treatments. Psychiatric Services 2009, 60:1466-1467.
15. Khan A., Khan S.R., Shankles E.B., Polissar N.L. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials. International Clinical Psychopharmacology 2002, 17:281-285.
16. Laje G., McMahon F.J. The pharmacogenetics of major depression: past, present, and future. Biological Psychiatry 2007, 62:1205-1207.
17. Leuchter A.F., Cook I.A., Hamilton S.P., Narr K.L., Toga A., Hunter A.M., Faull K., Whitelegge J., Andrews A.M., Loo J., Way B., Nelson S.F., Horvath S., Lebowitz B.D. Biomarkers to predict antidepressant response. Current Psychiatry Report 2010, 12:553-562.
18. Machado-Vieira R., Yuan P., Brutsche N., DiazGranados N., Luckenbaugh D., Manji H.K., Zarate C.A. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-d-aspartate antagonist. The Journal of Clinical Psychiatry 2009, 70:1662-1666.
19. MacQueen G.M., Yucel K., Taylor V.H., Macdonald K., Joffe R. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biological Psychiatry 2008, 64:880-883.
20. McNair D.M., Lorr M., Droppleman L.F. EITS Manual for the Profile of Mood States 1971, Educational and Industrial Testing Service, San Diego, CA.
21. Miskowiak K.W., Favaron E., Hafizi S., Inkster B., Goodwin G.M., Cowen P.J., Harmer C.J. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology 2009, 207:133-142.
22. Miskowiak K.W., Favaron E., Hafizi S., Inkster B., Goodwin G.M., Cowen P.J., Harmer C.J. Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology 2010, 210:419-428.
23. Murphy F.C., Sahakian B.J., Rubinsztein J.S., Michael A., Rogers R.D., Robbins T.W., Paykel E.S. Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine 1999, 29:1307-1321.
24. Nelson J.C., Mazure C.M., Jatlow P.I. Characteristics of desipramine-refractory depression. The Journal of Clinical Psychiatry 1994, 55:12-19.
25. Nierenberg A.A., DeCecco L.M. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. The Journal of Clinical Psychiatry 2001, 62(Suppl 16):5-9.
26. Peselow E.D., Sanfilipo M.P., Difiglia C., Fieve R.R. Melancholic/endogenous depression and response to somatic treatment and placebo. American Journal of Psychiatry 1992, 149:1324-1334.
27. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
28. Quitkin F.M., Stewart J.W., McGrath P.J., Tricamo E., Rabkin J.G., Ocepek-Welikson K., Nunes E., Harrison W., Klein D.F. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. The British Journal of Psychiatry. Supplement 1993, 30-34.
29. Roose S.P., Glassman A.H., Walsh B.T., Woodring S. Tricyclic nonresponders: phenomenology and treatment. American Journal of Psychiatry 1986, 143:345-348.
30. Salvadore G., Cornwell B.R., Colon-Rosario V., Coppola R., Grillon C., Zarate C.A., Manji H.K. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biological Psychiatry 2009, 65:289-295.
31. Salvadore G., Cornwell B.R., Sambataro F., Latov D., Colon-Rosario V., Carver F., Holroyd T., DiazGranados N., Machado-Vieira R., Grillon C., Drevets W.C., Zarate C.A. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology 2010, 35:1415-1422.
32. Simon G.E., Perlis R.H. Personalized medicine for depression: can we match patients with treatments?. American Journal of Psychiatry 2010, 167:1445-1455.
33. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 2004, 161:1957-1966.
34. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry 1978, 133:429-435.